Hepatitis C virus treatment pre- and post-liver transplantation.
about
Interferon-free regimens for the treatment of hepatitis C virus in liver transplant candidates or recipientsOutcomes and management of viral hepatitis and human immunodeficiency virus co-infection in liver transplantationΜanagement of patients with hepatitis B and C before and after liver and kidney transplantationManagement of patients with hepatitis B in special populationsTherapy with Direct-Acting Antiviral Agents for Hepatitis C-Related Liver CirrhosisManagement of hepatitis C infection before and after liver transplantationTelaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy data.Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients.Determining major genotypes of hepatitis C virus among transplant recipients by real-time polymerase chain reaction assayEvaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication--a comparative study.Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver TransplantationOutcomes for patients with HCV after liver transplantation in Korea: a multicenter studyLiving-donor liver transplantation and hepatitis CPsychometric Properties of a Standardized Questionnaire of Knowledge, Attitude, and Practice of Iranian Medical Specialists about Viral Hepatitis.SASLT practice guidelines: management of hepatitis C virus infection.A survey of hepatitis C treatment clinical practice patterns using the newly approved protease inhibitors.Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Long-term leukocyte natural α-interferon and ribavirin treatment in hepatitis C virus recurrence after liver transplantation.Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation.Reactivation of hepatitis viruses following immunomodulating systemic chemotherapy.Hepatitis B and C in liver transplantation: new strategies to combat the enemies.A pill for HCV - myth or foreseeable future?Management of Hepatitis C Before and After Liver Transplantation in the Era of Rapidly Evolving Therapeutic Advances.Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals.Effect of prior hepatitis B virus exposure on long-term risk of liver-related events after liver transplantation.Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list.Cost-effectiveness of Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir+Ribavirin for US Post-Liver Transplant Recurrent Genotype 1 HCV.Sofosbuvir plus simeprevir treatment of recurrent genotype 1 hepatitis C after liver transplant.Use of protease inhibitors in liver transplant recipients.Hepatitis C, stigma and cure.Understanding the switchbacks: the impact of direct antivirals on the minimization of hepatitis C virus recurrence after transplantation.Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.Liver transplantation and hepatitis C
P2860
Q26795595-3CE28C5D-233B-4FA3-98F1-D782BE1F94F5Q26864478-7E152942-8AB2-4448-8334-F3FFD3E43F00Q26864647-D0447BC6-7CFA-41EA-AAC4-B626B1EA558FQ27016136-8BEAE91E-A75C-442C-998E-D79FB33DCE8AQ28070260-1AA4D7A0-DDBA-48EB-AB73-4BC3864B131CQ28081250-A1D9D52C-A6B8-429E-BFF6-4425E82DE50DQ30560759-EE4BDDB4-3C07-431D-8CBF-70EBF290A026Q34168552-3457D130-8FE8-4FC1-81C5-DDB1AB2AE47AQ35157630-A9FF30E0-C82D-4E79-8583-25607E46EDC9Q35565539-4C724979-7167-4E37-8625-73D067774CE0Q35790393-81312539-4388-4F33-87A6-A105A17EAE09Q36241697-D7C029AC-4866-4960-9283-E4BCF8C72067Q36476188-3A636F6D-7C79-4627-97B1-CAAECFDE00EBQ36587253-02E1983E-6FEA-4A7D-BA45-E332AE0D3AA4Q36631782-2A31EDDF-AA8E-436D-9B2A-F1C790B91422Q37019765-8131B90A-2C0A-4662-967F-12147815A584Q37067537-EBF18579-FDC0-40A8-A03A-F1E714559E17Q37098646-810A98B3-7CCA-4B4B-8423-7CAA334886CCQ37118828-ABFE94A3-9329-40D5-AA8F-C40724E91A08Q38053172-6A118445-EF5A-49E6-9689-B5A9DFA56D79Q38062943-B063B19D-32CE-4DDF-A4BF-DA795C2B2ABBQ38067343-1A53F698-FFB6-479D-9392-8D86FDFCD1F3Q38133640-412283DA-283D-43D7-B1EB-57C7C21A2EF5Q38584289-7A79884E-BD46-420E-A246-9933E44F35D7Q38716554-EDBD107D-1021-4948-AE04-B3CF1E5DC8FDQ38749310-65187CCB-9526-43BE-B29B-CF25CAB4F23EQ39139767-D2B9C25B-A78C-4EF4-B27A-2DCD846D24B1Q40271866-0AE15C5A-EA62-4E2B-B61F-5878434E84E5Q41006072-7F129181-EA26-46F2-9AAB-BD26903EBDBBQ42182732-CAE7241F-898A-4712-BB1D-615D7215DD36Q42928878-8C369C2A-51C2-4BAA-AD82-DC261B162D9DQ42983195-AE8F1A15-54B1-445E-A1B6-79C50FA624A0Q45325465-78DF3D2C-191A-4C44-98ED-3ECD075FF582Q58704499-939767BD-0311-4395-BF64-57FB0A5DBD14
P2860
Hepatitis C virus treatment pre- and post-liver transplantation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Hepatitis C virus treatment pre- and post-liver transplantation.
@en
Hepatitis C virus treatment pre- and post-liver transplantation.
@nl
type
label
Hepatitis C virus treatment pre- and post-liver transplantation.
@en
Hepatitis C virus treatment pre- and post-liver transplantation.
@nl
prefLabel
Hepatitis C virus treatment pre- and post-liver transplantation.
@en
Hepatitis C virus treatment pre- and post-liver transplantation.
@nl
P2860
P1433
P1476
Hepatitis C virus treatment pre- and post-liver transplantation
@en
P2093
Bruno Roche
P2860
P304
P356
10.1111/J.1478-3231.2011.02714.X
P478
32 Suppl 1
P577
2012-02-01T00:00:00Z